0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Keratosis Pilaris Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-16X5935
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Keratosis Pilaris Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Keratosis Pilaris Treatment Market Research Report 2025

Code: QYRE-Auto-16X5935
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Keratosis Pilaris Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Keratosis Pilaris Treatment Market

Keratosis Pilaris Treatment Market

The global market for Keratosis Pilaris Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Keratosis pilaris is a common, harmless skin condition. It causes small, hard bumps that may make your skin feel like sandpaper.The bumps are often light-colored. They usually appear on your upper arms, thighs, and buttocks, sometimes with redness or swelling. They can also show up on your face, but that"s less common.Keratosis pilaris is caused by a buildup of keratin, the protein that protects skin from infections and other harmful things. The buildup forms a plug that blocks the opening of a hair follicle, but doctors don"t know what triggers the buildup.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Keratosis Pilaris Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Keratosis Pilaris Treatment.
The Keratosis Pilaris Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Keratosis Pilaris Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Keratosis Pilaris Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Keratosis Pilaris Treatment Market Report

Report Metric Details
Report Name Keratosis Pilaris Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company DERMAdoctor, First Aid Beauty (P&G), CeraVe (L'Oréal), SLMD Skincare, Paula’s Choice, AmLactin (Novartis), Eucerin (Beiersdorf AG), Neutrogena (Johnson & Johnson), Nip + Fab, Excipial (Galderma), Touch Skin Care
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Keratosis Pilaris Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Keratosis Pilaris Treatment Market report?

Ans: The main players in the Keratosis Pilaris Treatment Market are DERMAdoctor, First Aid Beauty (P&G), CeraVe (L'Oréal), SLMD Skincare, Paula’s Choice, AmLactin (Novartis), Eucerin (Beiersdorf AG), Neutrogena (Johnson & Johnson), Nip + Fab, Excipial (Galderma), Touch Skin Care

What are the Application segmentation covered in the Keratosis Pilaris Treatment Market report?

Ans: The Applications covered in the Keratosis Pilaris Treatment Market report are For Body, For Facial Skin

What are the Type segmentation covered in the Keratosis Pilaris Treatment Market report?

Ans: The Types covered in the Keratosis Pilaris Treatment Market report are Lotion, Body Scrub, Body Wash & Shower Gel, Other

Recommended Reports

Dermatology Treatments

Acne & Scar Care

Skin Disease Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Keratosis Pilaris Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Lotion
1.2.3 Body Scrub
1.2.4 Body Wash & Shower Gel
1.2.5 Other
1.3 Market by Application
1.3.1 Global Keratosis Pilaris Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 For Body
1.3.3 For Facial Skin
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Keratosis Pilaris Treatment Market Perspective (2020-2031)
2.2 Global Keratosis Pilaris Treatment Growth Trends by Region
2.2.1 Global Keratosis Pilaris Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Keratosis Pilaris Treatment Historic Market Size by Region (2020-2025)
2.2.3 Keratosis Pilaris Treatment Forecasted Market Size by Region (2026-2031)
2.3 Keratosis Pilaris Treatment Market Dynamics
2.3.1 Keratosis Pilaris Treatment Industry Trends
2.3.2 Keratosis Pilaris Treatment Market Drivers
2.3.3 Keratosis Pilaris Treatment Market Challenges
2.3.4 Keratosis Pilaris Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Keratosis Pilaris Treatment Players by Revenue
3.1.1 Global Top Keratosis Pilaris Treatment Players by Revenue (2020-2025)
3.1.2 Global Keratosis Pilaris Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Keratosis Pilaris Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Keratosis Pilaris Treatment Revenue
3.4 Global Keratosis Pilaris Treatment Market Concentration Ratio
3.4.1 Global Keratosis Pilaris Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Keratosis Pilaris Treatment Revenue in 2024
3.5 Global Key Players of Keratosis Pilaris Treatment Head office and Area Served
3.6 Global Key Players of Keratosis Pilaris Treatment, Product and Application
3.7 Global Key Players of Keratosis Pilaris Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Keratosis Pilaris Treatment Breakdown Data by Type
4.1 Global Keratosis Pilaris Treatment Historic Market Size by Type (2020-2025)
4.2 Global Keratosis Pilaris Treatment Forecasted Market Size by Type (2026-2031)
5 Keratosis Pilaris Treatment Breakdown Data by Application
5.1 Global Keratosis Pilaris Treatment Historic Market Size by Application (2020-2025)
5.2 Global Keratosis Pilaris Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Keratosis Pilaris Treatment Market Size (2020-2031)
6.2 North America Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Keratosis Pilaris Treatment Market Size by Country (2020-2025)
6.4 North America Keratosis Pilaris Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Keratosis Pilaris Treatment Market Size (2020-2031)
7.2 Europe Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Keratosis Pilaris Treatment Market Size by Country (2020-2025)
7.4 Europe Keratosis Pilaris Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Keratosis Pilaris Treatment Market Size (2020-2031)
8.2 Asia-Pacific Keratosis Pilaris Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Keratosis Pilaris Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Keratosis Pilaris Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Keratosis Pilaris Treatment Market Size (2020-2031)
9.2 Latin America Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Keratosis Pilaris Treatment Market Size by Country (2020-2025)
9.4 Latin America Keratosis Pilaris Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Keratosis Pilaris Treatment Market Size (2020-2031)
10.2 Middle East & Africa Keratosis Pilaris Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DERMAdoctor
11.1.1 DERMAdoctor Company Details
11.1.2 DERMAdoctor Business Overview
11.1.3 DERMAdoctor Keratosis Pilaris Treatment Introduction
11.1.4 DERMAdoctor Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.1.5 DERMAdoctor Recent Development
11.2 First Aid Beauty (P&G)
11.2.1 First Aid Beauty (P&G) Company Details
11.2.2 First Aid Beauty (P&G) Business Overview
11.2.3 First Aid Beauty (P&G) Keratosis Pilaris Treatment Introduction
11.2.4 First Aid Beauty (P&G) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.2.5 First Aid Beauty (P&G) Recent Development
11.3 CeraVe (L'Oréal)
11.3.1 CeraVe (L'Oréal) Company Details
11.3.2 CeraVe (L'Oréal) Business Overview
11.3.3 CeraVe (L'Oréal) Keratosis Pilaris Treatment Introduction
11.3.4 CeraVe (L'Oréal) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.3.5 CeraVe (L'Oréal) Recent Development
11.4 SLMD Skincare
11.4.1 SLMD Skincare Company Details
11.4.2 SLMD Skincare Business Overview
11.4.3 SLMD Skincare Keratosis Pilaris Treatment Introduction
11.4.4 SLMD Skincare Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.4.5 SLMD Skincare Recent Development
11.5 Paula’s Choice
11.5.1 Paula’s Choice Company Details
11.5.2 Paula’s Choice Business Overview
11.5.3 Paula’s Choice Keratosis Pilaris Treatment Introduction
11.5.4 Paula’s Choice Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.5.5 Paula’s Choice Recent Development
11.6 AmLactin (Novartis)
11.6.1 AmLactin (Novartis) Company Details
11.6.2 AmLactin (Novartis) Business Overview
11.6.3 AmLactin (Novartis) Keratosis Pilaris Treatment Introduction
11.6.4 AmLactin (Novartis) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.6.5 AmLactin (Novartis) Recent Development
11.7 Eucerin (Beiersdorf AG)
11.7.1 Eucerin (Beiersdorf AG) Company Details
11.7.2 Eucerin (Beiersdorf AG) Business Overview
11.7.3 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Introduction
11.7.4 Eucerin (Beiersdorf AG) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.7.5 Eucerin (Beiersdorf AG) Recent Development
11.8 Neutrogena (Johnson & Johnson)
11.8.1 Neutrogena (Johnson & Johnson) Company Details
11.8.2 Neutrogena (Johnson & Johnson) Business Overview
11.8.3 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Introduction
11.8.4 Neutrogena (Johnson & Johnson) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.8.5 Neutrogena (Johnson & Johnson) Recent Development
11.9 Nip + Fab
11.9.1 Nip + Fab Company Details
11.9.2 Nip + Fab Business Overview
11.9.3 Nip + Fab Keratosis Pilaris Treatment Introduction
11.9.4 Nip + Fab Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.9.5 Nip + Fab Recent Development
11.10 Excipial (Galderma)
11.10.1 Excipial (Galderma) Company Details
11.10.2 Excipial (Galderma) Business Overview
11.10.3 Excipial (Galderma) Keratosis Pilaris Treatment Introduction
11.10.4 Excipial (Galderma) Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.10.5 Excipial (Galderma) Recent Development
11.11 Touch Skin Care
11.11.1 Touch Skin Care Company Details
11.11.2 Touch Skin Care Business Overview
11.11.3 Touch Skin Care Keratosis Pilaris Treatment Introduction
11.11.4 Touch Skin Care Revenue in Keratosis Pilaris Treatment Business (2020-2025)
11.11.5 Touch Skin Care Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Keratosis Pilaris Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Lotion
 Table 3. Key Players of Body Scrub
 Table 4. Key Players of Body Wash & Shower Gel
 Table 5. Key Players of Other
 Table 6. Global Keratosis Pilaris Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Keratosis Pilaris Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Keratosis Pilaris Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Keratosis Pilaris Treatment Market Share by Region (2020-2025)
 Table 10. Global Keratosis Pilaris Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Keratosis Pilaris Treatment Market Share by Region (2026-2031)
 Table 12. Keratosis Pilaris Treatment Market Trends
 Table 13. Keratosis Pilaris Treatment Market Drivers
 Table 14. Keratosis Pilaris Treatment Market Challenges
 Table 15. Keratosis Pilaris Treatment Market Restraints
 Table 16. Global Keratosis Pilaris Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Keratosis Pilaris Treatment Market Share by Players (2020-2025)
 Table 18. Global Top Keratosis Pilaris Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Keratosis Pilaris Treatment as of 2024)
 Table 19. Ranking of Global Top Keratosis Pilaris Treatment Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Keratosis Pilaris Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Keratosis Pilaris Treatment, Headquarters and Area Served
 Table 22. Global Key Players of Keratosis Pilaris Treatment, Product and Application
 Table 23. Global Key Players of Keratosis Pilaris Treatment, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Keratosis Pilaris Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Keratosis Pilaris Treatment Revenue Market Share by Type (2020-2025)
 Table 27. Global Keratosis Pilaris Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Keratosis Pilaris Treatment Revenue Market Share by Type (2026-2031)
 Table 29. Global Keratosis Pilaris Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Keratosis Pilaris Treatment Revenue Market Share by Application (2020-2025)
 Table 31. Global Keratosis Pilaris Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Keratosis Pilaris Treatment Revenue Market Share by Application (2026-2031)
 Table 33. North America Keratosis Pilaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Keratosis Pilaris Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Keratosis Pilaris Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Keratosis Pilaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Keratosis Pilaris Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Keratosis Pilaris Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Keratosis Pilaris Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Keratosis Pilaris Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Keratosis Pilaris Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Keratosis Pilaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Keratosis Pilaris Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Keratosis Pilaris Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Keratosis Pilaris Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 48. DERMAdoctor Company Details
 Table 49. DERMAdoctor Business Overview
 Table 50. DERMAdoctor Keratosis Pilaris Treatment Product
 Table 51. DERMAdoctor Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 52. DERMAdoctor Recent Development
 Table 53. First Aid Beauty (P&G) Company Details
 Table 54. First Aid Beauty (P&G) Business Overview
 Table 55. First Aid Beauty (P&G) Keratosis Pilaris Treatment Product
 Table 56. First Aid Beauty (P&G) Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 57. First Aid Beauty (P&G) Recent Development
 Table 58. CeraVe (L'Oréal) Company Details
 Table 59. CeraVe (L'Oréal) Business Overview
 Table 60. CeraVe (L'Oréal) Keratosis Pilaris Treatment Product
 Table 61. CeraVe (L'Oréal) Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 62. CeraVe (L'Oréal) Recent Development
 Table 63. SLMD Skincare Company Details
 Table 64. SLMD Skincare Business Overview
 Table 65. SLMD Skincare Keratosis Pilaris Treatment Product
 Table 66. SLMD Skincare Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 67. SLMD Skincare Recent Development
 Table 68. Paula’s Choice Company Details
 Table 69. Paula’s Choice Business Overview
 Table 70. Paula’s Choice Keratosis Pilaris Treatment Product
 Table 71. Paula’s Choice Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 72. Paula’s Choice Recent Development
 Table 73. AmLactin (Novartis) Company Details
 Table 74. AmLactin (Novartis) Business Overview
 Table 75. AmLactin (Novartis) Keratosis Pilaris Treatment Product
 Table 76. AmLactin (Novartis) Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 77. AmLactin (Novartis) Recent Development
 Table 78. Eucerin (Beiersdorf AG) Company Details
 Table 79. Eucerin (Beiersdorf AG) Business Overview
 Table 80. Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product
 Table 81. Eucerin (Beiersdorf AG) Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 82. Eucerin (Beiersdorf AG) Recent Development
 Table 83. Neutrogena (Johnson & Johnson) Company Details
 Table 84. Neutrogena (Johnson & Johnson) Business Overview
 Table 85. Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product
 Table 86. Neutrogena (Johnson & Johnson) Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 87. Neutrogena (Johnson & Johnson) Recent Development
 Table 88. Nip + Fab Company Details
 Table 89. Nip + Fab Business Overview
 Table 90. Nip + Fab Keratosis Pilaris Treatment Product
 Table 91. Nip + Fab Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 92. Nip + Fab Recent Development
 Table 93. Excipial (Galderma) Company Details
 Table 94. Excipial (Galderma) Business Overview
 Table 95. Excipial (Galderma) Keratosis Pilaris Treatment Product
 Table 96. Excipial (Galderma) Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 97. Excipial (Galderma) Recent Development
 Table 98. Touch Skin Care Company Details
 Table 99. Touch Skin Care Business Overview
 Table 100. Touch Skin Care Keratosis Pilaris Treatment Product
 Table 101. Touch Skin Care Revenue in Keratosis Pilaris Treatment Business (2020-2025) & (US$ Million)
 Table 102. Touch Skin Care Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Keratosis Pilaris Treatment Picture
 Figure 2. Global Keratosis Pilaris Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Keratosis Pilaris Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Lotion Features
 Figure 5. Body Scrub Features
 Figure 6. Body Wash & Shower Gel Features
 Figure 7. Other Features
 Figure 8. Global Keratosis Pilaris Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Keratosis Pilaris Treatment Market Share by Application: 2024 VS 2031
 Figure 10. For Body Case Studies
 Figure 11. For Facial Skin Case Studies
 Figure 12. Keratosis Pilaris Treatment Report Years Considered
 Figure 13. Global Keratosis Pilaris Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Keratosis Pilaris Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Keratosis Pilaris Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Keratosis Pilaris Treatment Market Share by Players in 2024
 Figure 17. Global Top Keratosis Pilaris Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Keratosis Pilaris Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Keratosis Pilaris Treatment Revenue in 2024
 Figure 19. North America Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Keratosis Pilaris Treatment Market Share by Country (2020-2031)
 Figure 21. United States Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Keratosis Pilaris Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Keratosis Pilaris Treatment Market Share by Region (2020-2031)
 Figure 33. China Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Keratosis Pilaris Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Keratosis Pilaris Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Keratosis Pilaris Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. DERMAdoctor Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 49. First Aid Beauty (P&G) Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 50. CeraVe (L'Oréal) Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 51. SLMD Skincare Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 52. Paula’s Choice Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 53. AmLactin (Novartis) Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 54. Eucerin (Beiersdorf AG) Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 55. Neutrogena (Johnson & Johnson) Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 56. Nip + Fab Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 57. Excipial (Galderma) Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 58. Touch Skin Care Revenue Growth Rate in Keratosis Pilaris Treatment Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Chronic Idiopathic Urticaria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38H16391
Tue Sep 23 00:00:00 UTC 2025

Add to Cart

Global Fungal Skin Disease Diagnostic Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17T16810
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global UVB Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z16496
Mon Sep 22 00:00:00 UTC 2025

Add to Cart

Global Vitiligo Phototherapy Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15I16746
Mon Sep 22 00:00:00 UTC 2025

Add to Cart